Mackay Shields LLC Puma Biotechnology, Inc. Transaction History

Mackay Shields LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$12.3 - $35.76 $168,300 - $489,304	-13,683 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$20.77 - $42.37 $51,925 - $105,925	2,500 Added 22.36%	13,683 $531,000
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $24,565 - $57,160	-1,224 Reduced 9.87%	11,183 $228,000
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $32,960 - $47,880	800 Added 6.89%	12,407 $569,000
Q2 2018 Aug 06, 2018	BUY	$48.3 - $68.25 $9,660 - $13,650	200 Added 1.75%	11,607 $687,000
Q1 2018 May 03, 2018	BUY	$59.7 - $99.25 $680,997 - $1.13 Million	11,407 New	11,407 $776,000

100

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $135M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.